LBI Secures Global Manufacturing Deal with Indomo for Acne Drug/Device Treatment
Read how Lifecore Biomedical’s new contract with Indomo expands its CDMO services in dermatology, boosting global reach and revenue prospects.
2 minutes to read
Lifecore Biomedical Inc
How Lifecore Biomedical’s Litigation and Sterile Injectable Strategy Shape 2025 Outlook
Explore Lifecore Biomedical’s recent stock moves, legal scrutiny from a Grabar Law Office class‑action, and growth prospects in the injectable therapeutics market.
4 minutes to read
Lifecore Biomedical Faces Financial Scrutiny Amid Market Volatility and Negative P/E Ratio
Lifecore Biomedical Inc’s financial health is under scrutiny due to a negative price-earnings ratio, stock volatility, and market capitalization that does not reflect its operational success.
2 minutes to read
Lifecore Biomedical Faces Market Volatility Amid Industry Challenges, Focuses on Innovation and Growth
Lifecore Biomedical’s stock has experienced significant volatility, but the company’s established market presence, specialized products, and focus on innovation position it for future growth and success in the health care sector.
2 minutes to read